Vaccination rates among kindergarteners reached a record high in California after a tougher vaccine law went into effect.
Sanofi Pasteur's dengue vaccine Dengvaxia will have to undergo phase 4 testing in Malaysia.
CAR-T and TCR therapies have seen a whirlwind few years. Is 2017 set to be the year we see a CAR-T therapy approved? On a mission to find out, we sat down with…
GlaxoSmithKline’s U.S. vaccine R&D head Ripley Ballou says emerging disease vaccine research needs a shakeup—and here's how.
Sanofi Pasteur agreed to pay more than $19.8 million to settle allegations that it overcharged the Department of Veterans Affairs for its products.
With the expanding definition of “health” in play, does the category warrant a separate show in a program like the Lions?
Even as Pfizer’s vaccine outfit suffers a painful Prevnar 13 slowdown around the world, the group may soon get a boost in Europe.
The U.S. government is pumping more money into anthrax bioterror preparedness.
Sen. Sanders blasted a proposed Zika license, saying Americans shouldn't have to "pay the highest price in the world for a vaccine we paid to help…
Those who counted President Donald Trump an ally against vaccines might be disappointed in his pick to lead the FDA.
A group of lawyers in China have drafted an open letter calling for more legislation to ensure vaccine safety.
More than 350 pro-vaccine groups expressed their “unequivocal support for the safety of vaccines” to the seemingly skeptical President Donald Trump.